Inactive Instrument

Highlights Rich Pharmaceuticals, Inc.

Equities

Geopulse Exploration, Inc. cancelled the acquisition of unknown stake in Rich Pharmaceuticals, Inc..	06/10/20	CI
Geopulse Exploration, Inc. signed an agreement to acquire unknown stake in Rich Pharmaceuticals, Inc..	06/10/19	CI
Rich Pharmaceuticals, Inc Announces Study Drug RP-323 Is A Potential Therapeutic Agent for the Treatment of Hodgkin's Lymphoma	14/03/18	CI
Rich Pharmaceuticals, Inc. Enters into Support and Collaboration Agreement with Mega Bridge, Inc	12/07/17	CI
Rich Pharmaceuticals, Inc. Reaches Agreement with I Tech Health Corp. to Form a Subsidiary and Launch CannCodex	21/03/17	CI
Rich Pharmaceuticals Agrees Additional Contract with Theradex Systems	23/06/16	CI
Rich Pharmaceuticals, Inc. Receives FDA Approval for a Phase 1/2 Study in AML & MDS	28/12/15	CI
Rich Pharmaceuticals, Inc. Announces Completion of the Manufacture of RP-323 Study Drug	04/02/15	CI
Li Deng Ke and Xiong Chao Jun acquired boiler business of Nepia, Inc. for $0.02 million.	24/07/13	CI

No results for this search